Form 4: BioCardia Director Facteau Acquires Shares and Warrants in Private Placement

Director Bill Facteau acquired 13,123 shares of BioCardia, Inc. common stock and warrants in a private placement on April 23, 2025.

Summary

• On April 23, 2025, Bill Facteau, a director of BioCardia, Inc., participated in a private placement.
• Facteau acquired 13,123 shares of common stock at a price of $1.905 per share.
• He also received warrants to purchase 13,123 shares of common stock at an exercise price of $1.905 per share, exercisable immediately and expiring on April 23, 2030.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports a transaction. The director's participation is a positive signal, but the overall impact is uncertain.

Positives

• The director's participation in the private placement could be seen as a sign of confidence in the company's future prospects.

Industry Context

Private placements are a common method for companies, especially smaller ones like BioCardia, to raise capital. Director participation is often viewed positively by investors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased investment.

Key Dates

Keywords

BioCardia, Facteau, private placement, warrants, common stock, director, BCDA, acquisition